Bioactivation of monocrotaline by P-450 3A in rat liver.
暂无分享,去创建一个
T. Kuriyama | K. Tatsumi | Y. Kasahara | S. Ohmori | M. Kitada | K. Sugito | S. Yamagata | K. Kiyatake | I. Kakusaka | Kazutoshi Sugito | Takayuki Kuriyama | Shigeru Ohmori | Mitsukazu Kitada | Ikuei Kakusaka | Shin-ichi Yamagata
[1] F. Guengerich,et al. Selective inhibitors of cytochromes P450. , 1994, Toxicology and applied pharmacology.
[2] A. Hacker. Dietary restriction, polyamines and monocrotaline-induced pulmonary hypertension. , 1993, Biochemical pharmacology.
[3] J. Wagner,et al. Effects of monocrotaline pyrrole on cultured rat pulmonary endothelium. , 1993, Toxicology and applied pharmacology.
[4] A. D. Jones,et al. COR pulmonale is caused by monocrotaline and dehydromonocrotaline, but not by glutathione or cysteine conjugates of dihydropyrrolizine. , 1993, Toxicology and applied pharmacology.
[5] R. Huxtable,et al. Detection of a reactive pyrrole in the hepatic metabolism of the pyrrolizidine alkaloid, monocrotaline. , 1992, Toxicology and applied pharmacology.
[6] J. Wagner,et al. Early indications of monocrotaline pyrrole-induced lung injury in rats. , 1991, Toxicology and applied pharmacology.
[7] C. Miranda,et al. Role of cytochrome P450IIIA4 in the metabolism of the pyrrolizidine alkaloid senecionine in human liver. , 1991, Carcinogenesis.
[8] D. Morin,et al. Metabolism of [14C]monocrotaline by isolated perfused rat liver. , 1991, Drug metabolism and disposition: the biological fate of chemicals.
[9] J. Reindel,et al. Lung vascular injury from monocrotaline pyrrole, a putative hepatic metabolite. , 1991, Advances in experimental medicine and biology.
[10] J. Wagner,et al. Development of morphologic, hemodynamic, and biochemical changes in lungs of rats given monocrotaline pyrrole. , 1990, Toxicology and applied pharmacology.
[11] F. Gonzalez,et al. Molecular genetics of the P-450 superfamily. , 1990, Pharmacology & therapeutics.
[12] R. Huxtable. Activation and pulmonary toxicity of pyrrolizidine alkaloids. , 1990, Pharmacology & therapeutics.
[13] D. Williams,et al. Bioactivation and detoxication of the pyrrolizidine alkaloid senecionine by cytochrome P-450 enzymes in rat liver. , 1989, Drug metabolism and disposition: the biological fate of chemicals.
[14] A. Molteni,et al. Monocrotaline pneumotoxicity in mice , 1989, Virchows Archiv B Cell Pathology Including Molecular Pathology.
[15] D. Waxman,et al. Regulation of rat hepatic cytochrome P-450: age-dependent expression, hormonal imprinting, and xenobiotic inducibility of sex-specific isoenzymes. , 1985, Biochemistry.
[16] P. Svoboda,et al. Vanadyl (VO2+) and vanadate (VO-3) ions inhibit the brain microsomal Na,K-ATPase with similar affinities. Protection by transferrin and noradrenaline. , 1984, Biochemical pharmacology.
[17] F. Guengerich,et al. Estimation of isozymes of microsomal cytochrome P-450 in rats, rabbits, and humans using immunochemical staining coupled with sodium dodecyl sulfate-polyacrylamide gel electrophoresis. , 1982, Biochemistry.
[18] I. White,et al. Estimation of metabolites of pyrrolizidine alkaloids in animal tissues. , 1970, Analytical biochemistry.
[19] U. K. Laemmli,et al. Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.
[20] Fulton Rm,et al. VENTRICULAR WEIGHT IN CARDIAC HYPERTROPHY , 1952 .
[21] O. H. Lowry,et al. Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.